Immunic, inc. to participate in investor conferences in august

New york, aug. 3, 2021 /prnewswire/ -- immunic, inc. (nasdaq: imux), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, today announced participation in the following investor conferences in august: august 9-10: btig virtual biotechnology conference 2021. daniel vitt, ph.d.
IMUX Ratings Summary
IMUX Quant Ranking